Impaired Insulin Secretion – Causes, Symptoms and Treatment
Impaired insulin secretion refers to the reduced or dysfunctional release of insulin from the pancreas. It is a key factor in the development of type 2 diabetes and leads to elevated blood glucose levels.
Wissenswertes über "Impaired Insulin Secretion"
Impaired insulin secretion refers to the reduced or dysfunctional release of insulin from the pancreas. It is a key factor in the development of type 2 diabetes and leads to elevated blood glucose levels.
What Is Impaired Insulin Secretion?
Impaired insulin secretion occurs when the beta cells of the pancreas fail to produce or release sufficient insulin to regulate blood glucose effectively. Insulin is an essential hormone that enables glucose to enter body cells from the bloodstream. When this process is disrupted, blood glucose levels rise -- a condition known as hyperglycemia. This dysfunction is a central feature of several metabolic disorders, most notably type 2 diabetes mellitus.
Causes
Impaired insulin secretion can result from a variety of underlying causes:
- Genetic predisposition: Specific gene mutations can impair beta cell function and insulin release.
- Type 2 diabetes mellitus: Progressive decline in beta cell function, often combined with insulin resistance.
- Type 1 diabetes mellitus: Autoimmune destruction of beta cells leads to near-total loss of insulin production.
- Chronic pancreatitis: Repeated or ongoing inflammation of the pancreas can permanently damage beta cells.
- Pancreatic cancer: Tumors of the pancreas may destroy insulin-producing tissue.
- Medications: Certain drugs such as corticosteroids or thiazide diuretics can inhibit insulin secretion.
- MODY (Maturity Onset Diabetes of the Young): A rare, monogenic form of diabetes characterized primarily by secretory defects.
Symptoms
The symptoms of impaired insulin secretion are closely linked to the resulting hyperglycemia:
- Excessive thirst (polydipsia)
- Frequent urination (polyuria)
- Fatigue and general weakness
- Unexplained weight loss despite normal or increased appetite
- Blurred vision
- Increased susceptibility to infections
- Poor wound healing
In the early stages, impaired insulin secretion often causes no noticeable symptoms and may only be detected through laboratory testing.
Diagnosis
Several tests are used to evaluate insulin secretion and its clinical consequences:
- Fasting blood glucose: Measurement of blood sugar after at least 8 hours without food.
- HbA1c: Reflects average blood glucose levels over the past 2 to 3 months.
- Oral glucose tolerance test (OGTT): Assesses how the body processes a defined glucose load.
- C-peptide measurement: C-peptide levels in the blood serve as a direct indicator of the body's own insulin production.
- Fasting and stimulated insulin levels: Direct measurement of insulin release capacity.
- Autoantibody testing: Used to rule out type 1 diabetes (e.g., GAD antibodies, islet cell antibodies).
Treatment
Treatment depends on the underlying cause and the severity of the secretory defect:
Lifestyle Modifications
In type 2 diabetes and early-stage secretory impairment, weight loss, regular physical activity, and a balanced diet can significantly improve beta cell function and insulin output.
Pharmacological Therapy
- Sulfonylureas and glinides: Directly stimulate insulin release from beta cells.
- GLP-1 receptor agonists: Promote glucose-dependent insulin secretion while offering beta cell protection.
- DPP-4 inhibitors (gliptins): Prolong the action of gut-derived incretin hormones that stimulate insulin release.
- Metformin: Primarily improves insulin sensitivity but supports overall metabolic regulation.
Insulin Therapy
In advanced disease -- particularly in type 1 diabetes or severe type 2 diabetes -- external insulin administration becomes necessary to achieve adequate blood glucose control.
Treatment of the Underlying Condition
When impaired insulin secretion is secondary to another condition, such as chronic pancreatitis or drug-induced dysfunction, addressing the primary cause is the priority.
References
- American Diabetes Association - Standards of Medical Care in Diabetes (2024). Diabetes Care, 47(Suppl. 1).
- Roeder PV, Wu B, Liu Y, Han W - Pancreatic regulation of glucose homeostasis. Experimental and Molecular Medicine (2016); 48: e219.
- World Health Organization (WHO) - Classification of Diabetes Mellitus (2019). WHO/NMH/NVI/19.1.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryImmunoglobulin Infusion
Osteomalacia
Tomes Process
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Cologne list
Calorie content
Related search terms: Impaired Insulin Secretion + Insulin Secretion Disorder + Insulin Secretory Defect + Insulin Secretion Impairment